Akari Therapeutics Plc Quarterly Liabilities, Current in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Akari Therapeutics Plc quarterly Liabilities, Current history and growth rate from Q4 2011 to Q2 2024.
  • Akari Therapeutics Plc Liabilities, Current for the quarter ending June 30, 2024 was $24M.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $24M Jun 30, 2024 8-K 2024-09-06
Q1 2024 $6.33M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $20.5M +$9.72M +90% Dec 31, 2023 8-K 2024-09-06
Q4 2022 $10.8M Dec 31, 2022 8-K 2024-09-06
Q4 2018 $4.92M -$6.93M -58.5% Dec 31, 2018 20-F 2019-04-23
Q2 2018 $8.28M -$864K -9.45% Jun 30, 2018 6-K 2018-09-27
Q4 2017 $11.8M +$134K +1.14% Dec 31, 2017 20-F 2019-04-23
Q2 2017 $9.14M -$7.85M -46.2% Jun 30, 2017 6-K 2017-08-10
Q4 2016 $11.7M -$9.41M -44.5% Dec 31, 2016 20-F 2018-07-18
Q2 2016 $17M +$16M +1670% Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 $16.5M +$15.6M +1719% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $21.1M +$20M +1703% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 $37.8M Sep 30, 2015 10-Q 2015-11-23
Q2 2015 $960K Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $910K Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $1.17M -$59.6K -4.84% Dec 31, 2014 10-K 2016-03-23
Q4 2013 $1.23M -$2.62M -68% Dec 31, 2013 10-K 2015-02-11
Q4 2012 $3.85M +$1.61M +72.2% Dec 31, 2012 20-F 2014-03-24
Q4 2011 $2.24M Dec 31, 2011 20-F/A 2013-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.